As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Zynerba Pharmaceuticals

  • Tuesday's Range: $5.17-$6.03
  • 52-Week Range: $4.64-$43.00
  • Tuesday's Volume: 265,000
  • Three-Month Average Volume: 70,672

Zynerba Pharmaceuticals  (ZYNE) , a specialty pharmaceutical company, focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. This stock traded up 2.9% to $5.95 in Tuesday's trading session.

From a technical perspective, Zynerba Pharmaceuticals jumped notably higher on Tuesday and displayed some relative strength versus the overall market weakness with above-average volume. This stock has been downtrending badly over the last five months, with shares falling sharply lower off its high of $33.06 to its new all-time low of $4.64 a share. During that downtrend, shares of Zynerba Pharmaceuticals have been making mostly lower highs and lower lows, which is bearish technical price action. That said, this high-volume spike to the upside on Tuesday is now pushing this stock within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out its 20-day moving average of $6.20 to some more near-term overhead resistance levels at $6.50 to $6.64 a share with high volume.

Traders should now look for long-biased trades in Zynerba Pharmaceuticals as long as it's trending above Tuesday's intraday low of $5.17 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 70,672 shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $7.07 to $8, or even its 50-day moving average of $8.68 a share.

BioDelivery Sciences

  • Tuesday's Range: $4.02-$4.24
  • 52-Week Range: $3.04-$15.50
  • Tuesdays Volume: 534,000
  • Three-Month Average Volume: 1.19 million

BioDelivery Sciences  (BDSI) , a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. This stock traded up 3.8% to $4.18 in Tuesday's trading session.

From a technical perspective, BioDelivery Sciences displayed some relative strength on Tuesday after the stock bounced higher right above its 20-day moving average of $3.89 a share with lighter-than-average volume. This bounce to the upside is now quickly pushing this stock within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to clear its 50-day moving average of $4.24 a share and then once it takes out more resistance at $4.26 a share with high volume.

Traders should now look for long-biased trades in BioDelivery Sciences as long as it's trending above its 20-day moving average of $3.89 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.19 million shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at just above $4.50 to $4.90, or even $5.25 to $5.50 a share.

Aratana Therapeutics

  • Tuesday's Range: $3.31-$3.68
  • 52-Week Range: $2.56-$20.63
  • Tuesday's Volume: 608,000
  • Three-Month Average Volume: 601,156

Aratana Therapeutics  (PETX) , a development-stage biopharmaceutical company, focuses on the licensing, development and commercialization of biopharmaceutical products for the companion animals worldwide. This stock traded up 5.3% to $3.54 in Tuesday's trading session.

From a technical perspective, Aratana Therapeutics ripped sharply higher on Tuesday and counter-trended versus the overall market weakness right above its 20-day moving average of $3.16 a share with decent upside volume flows. This strength pushed this stock into breakout territory, after it cleared and closed above some near-term overhead resistance at $3.50 a share. Market players should now look for a continuation move to the upside in the short-term if shares of Aratana Therapeutics manage to take out Tuesday's intraday high of $3.68 a share with strong upside volume flows.

Traders should now look for long-biased trades in Aratana Therapeutics as long as it's trending above Tuesday's intraday low of $3.31 or above its 20-day moving average of $3.16 a share and then once it sustains a move or close above $3.68 a share with volume that hits near or above 601,156 shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $4.11 to $4.19, or even $4.50 to $5 a share.

Medovex

  • Tuesday's Range: $1.40-$1.55
  • 52-Week Range: $0.85-$5.80
  • Tuesday's Volume: 74,000
  • Three-Month Average Volume: 50,466

Medovex  (MDVX)  focuses on the development of medical devices. This stock traded up 8.3% to $1.51 in Tuesday's trading session.

From a technical perspective, Medovex displayed some relative strength on Tuesday after it spiked sharply higher right off its 20-day moving average of $1.40 a share with above-average volume. This high-volume strength to the upside is now quickly pushing shares of Medovex within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.55 to $1.56 a share with high volume.

Traders should now look for long-biased trades in Medovex as long as it's trending above its 20-day moving average of $1.40 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 50,466 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.70 to $1.85, or even $1.95 to $2 a share.

WP Glimcher

  • Tuesday's Range: $7.80-$8.20
  • 52-Week Range: $7.41-$17.79
  • Tuesday's Volume: 1.54 million
  • Three-Month Average Volume: 1.45 million

WP Glimcher  (WPG)  is a self-administered and self-managed real estate investment trust. This stock traded up 4.6% to $8.18 in Tuesday's trading session.

From a technical perspective, WP Glimcher rallied sharply higher on Tuesday and counter-trended versus the overall market weakness with above-average volume. This high-volume spike to the upside managed to push this stock into breakout territory, after it cleared and closed above some near-term overhead resistance at $8.01 a share. Market players should now look for a continuation move to the upside in the short-term if shares of WP Glimcher can manage to clear both Tuesday's intraday high of $8.20 a share and its 20-day moving average of $8.27 a share with strong upside volume flows.

Traders should now look for long-biased trades in WP Glimcher as long as it's trending above Tuesday's intraday low of $7.80 a share and then once it sustains a move or close above $8.20 to $8.27 a share with volume that hits near or above 1.45 million shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.50 to $9.17, or even its 50-day moving average of $9.43 a share.


Dipexium Pharmaceuticals

  • Tuesday's Range: $7.05-$7.90
  • 52-Week Range: $6.04-$17.10
  • Tuesday's Volume: 26,000
  • Three-Month Average Volume: 31,434

Dipexium Pharmaceuticals  (DPRX) , a biopharmaceutical company, focuses on the development and commercialization of antibiotics for the treatment of infectious diseases. This stock traded up 9.9% to $7.86 in Tuesday's trading session.

From a technical perspective, Dipexium Pharmaceuticals ripped sharply higher on Tuesday back above its 20-day moving average of $7.48 a share with lighter-than-average volume. This counter-trend to the upside in a very weak tape is now quickly pushing shares of Dipexium Pharmaceuticals within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out Tuesday's intraday high of $7.90 a share and then once it clears more key resistance levels at $8 to around $8.25 a share with high volume.

Traders should now look for long-biased trades in Dipexium Pharmaceuticals as long as it's trending above its 20-day moving average of $7.48 or above more near-term support at $7 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 31,434 shares. If that breakout gets set off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.90 to its 50-day moving average of $9.07, or even $9.50 a share.

Ohr Pharmaceutical

  • Tuesday's Range: $3.00-$3.46
  • 52-Week Range: $2.02-$12.31
  • Tuesday's Volume: 325,000
  • Three-Month Average Volume: 473,934

Ohr Pharmaceutical  (OHRP) , a pharmaceutical company, focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. This stock traded up 8.2% to $3.28 in Tuesday's trading session.

From a technical perspective, Ohr Pharmaceuticals displayed some relative strength on Tuesday versus the overall market weakness after it ripped sharply higher right off some near-term support at $3 a share with decent upside volume flows. This spike to the upside briefly pushed this stock back above both its 200-day moving average of $3.31 and its 20-day moving average of $3.35 a share, before it closed at $3.28 a share. Shares of Ohr Pharmaceuticals are now quickly moving within range of triggering a near-term breakout trade above some key overhead resistance levels. That breakout will trigger if this stock manages to take out some near-term overhead resistance levels at $3.47 to around $3.50 a share with high volume.

Traders should now look for long-biased trades in Ohr Pharmaceuticals as long as it's trending above some near-term support at $3 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 473,934 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $3.75 to $4, or even its 50-day moving average of $4.25 a share.

Vringo

  • Tuesday's Range: $2.02-$2.58
  • 52-Week Range: $1.18-$9.20
  • Tuesday's Volume: 1.05 million
  • Three-Month Average Volume: 242,123

Vringo  (VRNG) , together with its subsidiaries, develops, acquires, licenses, protects and monetizes intellectual property worldwide. This stock traded up 6.9% to $2.32 in Tuesday's trading session.

From a technical perspective, Vringo counter-trended higher on Tuesday versus the overall market weakness right off its 50-day moving average of $2 a share with strong upside volume flows. This stock has been uptrending strong with heavy upside volume flows over the last few trading sessions, with shares moving higher off its low of $1.18 to its intraday high on Tuesday of $2.58 a share. During that uptrend, shares of Vringo have been making mostly higher lows and higher highs, which is bullish technical price action. This high-volume spike to the upside on Tuesday is now quickly pushing this stock within range of triggering a big breakout trade. That breakout will trigger if this stock manages to take out some key overhead resistance levels at $2.58 to $2.92 a share with high volume.

Traders should now look for long-biased trades in Vringo as long as it's trending above its 50-day moving average of $2 a share or above $1.86 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 242,123 shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $3.70 to $3.80, or even $3.90 to $4 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Opinion

Facebook Needs to Tread Carefully Now That Instagram's Co-Founders Are Leaving

Facebook Needs to Tread Carefully Now That Instagram's Co-Founders Are Leaving

Tuesday Turnaround: Tilray's Toking

Tuesday Turnaround: Tilray's Toking

3 Software Stocks Now Available at a Discount

3 Software Stocks Now Available at a Discount

Microsoft Takes Aim at Oracle, Amazon and Others With Ignite Announcements

Microsoft Takes Aim at Oracle, Amazon and Others With Ignite Announcements

Monday Madness: Nike Just Does It

Monday Madness: Nike Just Does It